Cornerstone Capital, Inc. - ACELRX PHARMACEUTICALS INC ownership

ACELRX PHARMACEUTICALS INC's ticker is ACRX and the CUSIP is 00444T100. A total of 56 filers reported holding ACELRX PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Cornerstone Capital, Inc. ownership history of ACELRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$17,000
-15.0%
80,0000.0%0.00%
-33.3%
Q2 2022$20,000
-13.0%
80,0000.0%0.00%0.0%
Q1 2022$23,000
-48.9%
80,0000.0%0.00%
-40.0%
Q4 2021$45,000
+95.7%
80,000
+372.0%
0.01%
+66.7%
Q2 2021$23,000
-41.0%
16,950
-25.2%
0.00%
-40.0%
Q1 2021$39,000
-66.4%
22,650
-75.7%
0.01%
-66.7%
Q4 2020$116,000
-12.8%
93,4000.0%0.02%
-21.1%
Q3 2020$133,000
+24.3%
93,400
+5.7%
0.02%
+5.6%
Q2 2020$107,000
+4.9%
88,400
+1.9%
0.02%
-14.3%
Q1 2020$102,000
-90.2%
86,750
-82.4%
0.02%
-85.6%
Q4 2019$1,037,000
+8.1%
491,560
+12.8%
0.15%
-2.0%
Q3 2019$959,000
-1.3%
435,810
+13.4%
0.15%
-2.0%
Q2 2019$972,000
+386.0%
384,360
+567.9%
0.15%
+360.6%
Q1 2019$200,000
+334.8%
57,550
+187.8%
0.03%
+312.5%
Q4 2018$46,000
-70.1%
20,000
-50.0%
0.01%
-65.2%
Q3 2018$154,000
+83.3%
40,0000.0%0.02%
+64.3%
Q1 2018$84,000
+3.7%
40,0000.0%0.01%0.0%
Q4 2017$81,000
+24.6%
40,000
+33.3%
0.01%
+16.7%
Q2 2017$65,000
-31.6%
30,0000.0%0.01%
-36.8%
Q1 2017$95,000
+15.9%
30,000
-4.5%
0.02%
+5.6%
Q4 2016$82,000
-46.8%
31,400
-20.9%
0.02%
-45.5%
Q3 2016$154,000
+21.3%
39,700
-15.9%
0.03%
+17.9%
Q2 2016$127,000
-12.4%
47,2000.0%0.03%
-12.5%
Q1 2016$145,000
-20.3%
47,2000.0%0.03%
-22.0%
Q4 2015$182,000
+0.6%
47,200
-20.3%
0.04%
-8.9%
Q3 2015$181,000
-27.9%
59,2000.0%0.04%
-22.4%
Q2 2015$251,00059,2000.06%
Other shareholders
ACELRX PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
Perceptive Advisors 6,574,060$27,874,0001.68%
SENZAR ASSET MANAGEMENT, LLC 798,381$3,385,0000.58%
Cormorant Asset Management, LP 850,000$3,604,0000.48%
Palo Alto Investors LP 2,135,739$9,056,0000.40%
Opus Point Partners Management, LLC 99,959$424,0000.34%
Granahan Investment Management 1,582,237$6,709,0000.19%
Joel Isaacson & Co., LLC 70,660$300,0000.08%
MARINER INVESTMENT GROUP LLC 59,700$253,0000.06%
MYCIO WEALTH PARTNERS, LLC 75,000$318,0000.06%
Cornerstone Capital, Inc. 59,200$251,0000.06%
View complete list of ACELRX PHARMACEUTICALS INC shareholders